000			01493 a2200397 4500
005			20250514034453.0
264		0	_c20020904
008			200209s 0 0 eng d
022			_a0168-8227
024	7		_a10.1016/s0168-8227(02)00022-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aTong, P C
245	0	0	_aThe contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin. _h[electronic resource]
260			_bDiabetes research and clinical practice _cAug 2002
300			_a93-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aBody Mass Index
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFasting
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin, Isophane _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPostprandial Period
650	0	4	_aSulfonylurea Compounds _xtherapeutic use
700	1		_aChow, C C
700	1		_aJorgensen, L N
700	1		_aCockram, C S
773	0		_tDiabetes research and clinical practice _gvol. 57 _gno. 2 _gp. 93-8
856	4	0	_uhttps://doi.org/10.1016/s0168-8227(02)00022-0 _zAvailable from publisher's website
999			_c11958280 _d11958280